Suven Pharmaceuticals Q2 FY25 Results
Suven Pharmaceuticals has released its financial results for the Q2 quarter of Financial Year 24-2025. Here's a comprehensive breakdown of the company's performance:
Revenue Analysis
- Current Quarter Revenue: Rs. 257.72 Cr
- Quarter-on-Quarter (QoQ) Change: 11.72% (Previous Quarter: Rs. 230.69 Cr )
- Year-on-Year (YoY) Change: 11.54% (Same Quarter Last Year: Rs. 231.05 Cr )
Profitability Metrics
- Net Profit: Rs. 81.98 Cr
- QoQ Profit Change: 34.93% (Previous Quarter: Rs. 60.76 Cr )
- YoY Profit Change: 3.04% (Same Quarter Last Year: Rs. 79.56 Cr )
Shareholder Returns
- Earnings Per Share (EPS): Rs. 3.23
- QoQ EPS Change: 35.15% (Previous Quarter: Rs. 2.39)
- YoY EPS Change: 3.19% (Same Quarter Last Year: Rs. 3.13)
Performance Summary
Moderate Growth
Suven Pharmaceuticals showed moderate growth, with earnings per share growing the most. This is positive for shareholders.
This analysis provides a snapshot of Suven Pharmaceuticals's financial performance. Investors and analysts should consider these results in the context of broader market trends and the company's long-term strategy.
Disclaimer:
This information is for informational purposes only. Please reverify all details from official sources before making any financial decisions. The accuracy and completeness of this data cannot be guaranteed.